UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Low‐dose growth hormone for 40 weeks induces HIV‐1‐specific T cell responses in patients on effective combination anti‐retroviral therapy

Clinical and experimental immunology, 2013-09, Vol.173 (3), p.444-453

2013

Volltextzugriff (PDF)

Low levels of neurocognitive impairment detected in screening HIV-infected men who have sex with men: The MSM Neurocog Study

International journal of STD & AIDS, 2017-06, Vol.28 (7), p.715-722

2017

Volltextzugriff (PDF)

Once-daily therapy: less is more

International journal of STD & AIDS, 2003-10, Vol.14 Suppl 1 (1_suppl), p.1-5

Moyle, G

2003

Volltextzugriff (PDF)

Mitochondrial toxicity hypothesis for lipoatrophy : a refutation

AIDS (London), 2001-02, Vol.15 (3), p.413-415

MOYLE, Graeme

2001

Volltextzugriff (PDF)

Dietary advice with or without pravastatin for the management of hypercholesterolaemia associated with protease inhibitor therapy

AIDS (London), 2001-08, Vol.15 (12), p.1503-1508

2001

Volltextzugriff (PDF)

Plasma and Cerebrospinal Fluid Saquinavir Concentrations in Patients Receiving Combination Antiretroviral Therapy

Clinical infectious diseases, 1999-02, Vol.28 (2), p.403-404

1999

Volltextzugriff (PDF)

Antiretroviral nucleoside and nucleotide analogues and mitochondria

AIDS (London), 2004-01, Vol.18 (2), p.137-151

2004

Volltextzugriff (PDF)

Differing reverse transcriptase mutation patterns in individuals experiencing viral rebound on first-line regimens with stavudine/didanosine and stavudine/lamivudine

AIDS (London), 2001-04, Vol.15 (6), p.799-800

2001

Volltextzugriff (PDF)

Frequency of multinucleoside analogue-resistant genotypes observed during antiretroviral therapy

AIDS (London), 2000-06, Vol.14 (9), p.1292-1293

2000

Volltextzugriff (PDF)

Renal dysfunction with tenofovir disoproxil fumarate-containing highly active antiretroviral therapy regimens is not observed more frequently: a cohort and case-control study

Journal of acquired immune deficiency syndromes (1999), 2004-12, Vol.37 (4), p.1489-1495

2004

Volltextzugriff (PDF)

Efficacy of selected treatments of HIV wasting: a systematic review and meta-analysis

Journal of acquired immune deficiency syndromes (1999), 2004-12, Vol.37 Suppl 5 (Supplement 1), p.S262-S276

2004

Volltextzugriff (PDF)

Salvage therapy with abacavir plus efavirenz or nevirapine in HIV-1-infected persons with previous nucleoside analogue and protease inhibitor use

AIDS (London), 2000-07, Vol.14 (10), p.1453-1454

2000

Volltextzugriff (PDF)

The development of resistance of HIV-1 to zalcitabine

AIDS (London), 1997-03, Vol.11 (3), p.271-279

1997

Volltextzugriff (PDF)

Influence of emergence of viral resistance on HIV treatment choice

International journal of STD & AIDS, 1995-05, Vol.6 (3), p.225-226

Moyle, G

1995

Volltextzugriff (PDF)

Coronary artery disease occurring with protease inhibitor therapy

International journal of STD & AIDS, 1998-11, Vol.9 (11), p.711-712

1998

Volltextzugriff (PDF)

Once weekly azithromycin as prophylaxis against recurrence of non-tuberculous mycobacterial infections in HIV-1-positive individuals

AIDS (London), 1998-08, Vol.12 (12), p.1555-1557

1998

Volltextzugriff (PDF)

Does earlier HIV RNA suppression provide long-term benefits?

AIDS (London), 2010-06, Vol.24 (10), p.1591-1593

2010

Volltextzugriff (PDF)

Discontinuation of Mycobacterium avium complex prophylaxis in patients with a rise in CD4 cell count following highly active antiretroviral therapy

AIDS (London), 1998-04, Vol.12 (6), p.680-680

1998

Volltextzugriff (PDF)

Restoration of Human Immunodeficiency Virus‐1‐Specific Responses in Patients Changing from Protease to Non‐Nucleoside Reverse Transcriptase Inhibitor‐Based Antiretroviral Therapy

Scandinavian journal of immunology, 2003-06, Vol.57 (6), p.600-607

2003

Volltextzugriff (PDF)

Clinical management of treatment-experienced, HIV-infected patients with the fusion inhibitor enfuvirtide: consensus recommendations

AIDS (London), 2004-05, Vol.18 (8), p.1137-1146

2004

Volltextzugriff (PDF)

Epidemiology, assessment, and management of excess abdominal fat in persons with HIV infection

AIDS reviews, 2010-01, Vol.12 (1), p.3-14

2010

Volltextzugriff (PDF)

Concurrent use of statins does not influence efficacy of maraviroc in Maraviroc versus Optimized Therapy in Viremic Antiretroviral Treatment-Experienced Patients 1 and 2 trials

AIDS (London), 2009-07, Vol.23 (12), p.1613-1613

2009

Volltextzugriff (PDF)

Steady-State pharmacokinetics of saquinavir hard-gel/ritonavir/fosamprenavir in HIV-1-infected patients

Journal of acquired immune deficiency syndromes (1999), 2004-11, Vol.37 (3), p.1376-1384

2004

Volltextzugriff (PDF)

Penile ulceration with foscarnet therapy

AIDS (London), 1993-01, Vol.7 (1), p.140-141

1993

Volltextzugriff (PDF)

Quality of life outcomes of combination zalcitabine-zidovudine, saquinavir-zidovudine, and saquinavir-zalcitabine-zidovudine therapy for HIV-infected adults with CD4 cell counts between 50 and 350 per cubic millimeter

AIDS (London), 1999-05, Vol.13 (7), p.851-858

1999

Volltextzugriff (PDF)

1 – 25 von 44

Suche als RSS-Feed

Aktive Filter

ThemaFemale

ThemaImmunology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(42)
Mit Volltextzugriff
(29)

Publikationsform

Artikel
(44)

Sprache

Englisch
(44)

Erscheinungsjahr

n.n

Thema

Science & Technology
(44)
Life Sciences & Biomedicine
(43)
Infectious Diseases
(38)
Humans
(37)
Aids/hiv
(28)
Hiv Infections - Drug Therapy
(28)
Biological And Medical Sciences
(25)
Medical Sciences
(25)
Virology
(19)
Human Immunodeficiency Virus
(17)
Pharmacology. Drug Treatments
(16)
Antiviral Agents
(14)
Hiv
(14)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(13)
Human Viral Diseases
(12)
Viral Diseases
(12)
Viral Diseases Of The Lymphoid Tissue And The Blood. Aids
(12)
Male
(11)
Anti-Hiv Agents - Therapeutic Use
(10)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Low‐dose growth hormone for 40 weeks induces HIV‐1‐specific T cell responses in patients on effective combination anti‐retroviral therapy

Low levels of neurocognitive impairment detected in screening HIV-infected men who have sex with men: The MSM Neurocog Study

Once-daily therapy: less is more

Mitochondrial toxicity hypothesis for lipoatrophy : a refutation

Dietary advice with or without pravastatin for the management of hypercholesterolaemia associated with protease inhibitor therapy

Plasma and Cerebrospinal Fluid Saquinavir Concentrations in Patients Receiving Combination Antiretroviral Therapy

Antiretroviral nucleoside and nucleotide analogues and mitochondria

Differing reverse transcriptase mutation patterns in individuals experiencing viral rebound on first-line regimens with stavudine/didanosine and stavudine/lamivudine

Frequency of multinucleoside analogue-resistant genotypes observed during antiretroviral therapy

Renal dysfunction with tenofovir disoproxil fumarate-containing highly active antiretroviral therapy regimens is not observed more frequently: a cohort and case-control study

Efficacy of selected treatments of HIV wasting: a systematic review and meta-analysis

Salvage therapy with abacavir plus efavirenz or nevirapine in HIV-1-infected persons with previous nucleoside analogue and protease inhibitor use

The development of resistance of HIV-1 to zalcitabine

Influence of emergence of viral resistance on HIV treatment choice

Coronary artery disease occurring with protease inhibitor therapy

Once weekly azithromycin as prophylaxis against recurrence of non-tuberculous mycobacterial infections in HIV-1-positive individuals

Does earlier HIV RNA suppression provide long-term benefits?

Discontinuation of Mycobacterium avium complex prophylaxis in patients with a rise in CD4 cell count following highly active antiretroviral therapy

Restoration of Human Immunodeficiency Virus‐1‐Specific Responses in Patients Changing from Protease to Non‐Nucleoside Reverse Transcriptase Inhibitor‐Based Antiretroviral Therapy

Clinical management of treatment-experienced, HIV-infected patients with the fusion inhibitor enfuvirtide: consensus recommendations

Epidemiology, assessment, and management of excess abdominal fat in persons with HIV infection

Concurrent use of statins does not influence efficacy of maraviroc in Maraviroc versus Optimized Therapy in Viremic Antiretroviral Treatment-Experienced Patients 1 and 2 trials

Steady-State pharmacokinetics of saquinavir hard-gel/ritonavir/fosamprenavir in HIV-1-infected patients

Penile ulceration with foscarnet therapy

Quality of life outcomes of combination zalcitabine-zidovudine, saquinavir-zidovudine, and saquinavir-zalcitabine-zidovudine therapy for HIV-infected adults with CD4 cell counts between 50 and 350 per cubic millimeter

Aktive Filter

Suchergebnisse filtern